PHGE Insider Trading Activity and SEC Form 4 Filings
PHGE insider trading summary
Over the past 12 months, insiders at BiomX Inc. (PHGE) reported 2 sales worth $4.9M by 1 insider and no open-market purchases on SEC Form 4. Net insider selling was $4.9M.
Latest PHGE insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 17, 2026 | Reuven Yeganeh | Director | Sell | $2.6M (530,000 @ $5.00) |
| Mar 16, 2026 | Reuven Yeganeh | Director | Sell | $2.3M (450,000 @ $5.00) |
| May 15, 2024 | Erez Chimovits | 10% Owner | Sell | $9K (24,344 @ $0.38) |
| May 15, 2024 | OrbiMed Israel BioFund GP Limited Partnership | 10% Owner | Sell | $9K (24,344 @ $0.38) |
| May 15, 2024 | OrbiMed Israel GP Ltd. | 10% Owner | Sell | $9K (24,344 @ $0.38) |
| May 15, 2024 | Carl L Gordon | 10% Owner | Sell | $9K (24,344 @ $0.38) |
| Nov 29, 2023 | Assaf Oron | Chief Business Officer | Sell | $2K (5,444 @ $0.40) |
| Nov 29, 2023 | Assaf Oron | Chief Business Officer | Sell | $1K (3,414 @ $0.35) |
| Nov 29, 2023 | Assaf Oron | Chief Business Officer | Sell | $699 (2,056 @ $0.34) |
| May 22, 2023 | Assaf Oron | Chief Business Officer | Buy | $872 (3,192 @ $0.27) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.